[The Conversation Africa] The exorbitant costs of cancer drugs make it difficult for public and private health care systems to provide the latest treatments to patients. If this trend continues it will become increasingly difficult for patients to access basic cancer treatment, let alone the new generation of immunotherapy drugs.
source https://allafrica.com/stories/201904300087.html
source https://allafrica.com/stories/201904300087.html
Comments
Post a Comment